Association Between High-Need Education-Based Funding and School Suspension Rates for Autistic Students in New Zealand.


Journal

JAMA pediatrics
ISSN: 2168-6211
Titre abrégé: JAMA Pediatr
Pays: United States
ID NLM: 101589544

Informations de publication

Date de publication:
01 07 2022
Historique:
pubmed: 17 5 2022
medline: 8 7 2022
entrez: 16 5 2022
Statut: ppublish

Résumé

Autistic students often experience poor educational outcomes that have implications for later life, including unemployment, interactions with the criminal justice system, increased risk for substance abuse, and low socioeconomic status. Improving educational outcomes is critical for ensuring that autistic young people can reach their potential. To quantify differences in suspension rates between autistic and nonautistic students and to assess whether high-need education-based funding for autistic students is associated with reduced rates of school suspension. This national cohort study used linked health and education data from New Zealand's Integrated Data Infrastructure. Data were obtained for students aged 5 to 16 years from January 1 to December 31, 2018, and analyzed July 7, 2021, to January 1, 2022. A novel case identification method was used to identify autistic students. High-need education-based funding (Ongoing Resourcing Scheme [ORS]) obtained before 2019. Rates of suspension from school. Crude and adjusted analyses of the association between suspension rates and autism among the full population with adjustment made for sociodemographic characteristics (sex, age, ethnicity, deprivation, and urban or rural profile of residence) were conducted using complete-case, 2-level random intercept logistic multivariable regressions. To assess the association between ORS funding and suspension, analysis was restricted to autistic students. Of the 736 911 students in the study population, 9741 (1.3%) were identified as autistic (median [SD] age, 10 [3.2] years; 7710 [79.1%] boys), and 727 170 (98.7%) as nonautistic (median [SD] age, 10 [3.4] years; 369 777 [50.9%] boys). School suspension was experienced by 504 autistic students (5.2%) and 13 845 nonautistic students (1.9%). After adjustment for demographic characteristics, autistic students had significantly higher odds of suspension than their nonautistic peers (adjusted odds ratio, 2.81; 95% CI, 2.55-3.11). Of the 9741 autistic students, 2895 (29.7%) received high-need education-based (ORS) funding. Suspensions were experienced by 57 autistic students (2.0%) with high-need funding and 447 autistic students (6.5%) without high-need funding. After adjustment for demographic characteristics, co-occurring conditions, and level of disability support need, autistic students with high-need funding had significantly lower odds of suspension than autistic students without high-need funding (adjusted odds ratio, 0.29; 95% CI, 0.21-0.40). In this cohort study, the findings of disparities in suspension rates between autistic and nonautistic students underscore the challenges faced in providing inclusive education for all young people, regardless of disability status. This study found that high-need funding was associated with reduced suspension rates among autistic students, suggesting that if appropriate supports are afforded to autistic students, a more inclusive education can be provided.

Identifiants

pubmed: 35576000
pii: 2792410
doi: 10.1001/jamapediatrics.2022.1296
pmc: PMC9112133
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

664-671

Références

J Autism Dev Disord. 2010 Jul;40(7):812-26
pubmed: 20054628
J Autism Dev Disord. 2015 May;45(5):1354-67
pubmed: 25374134
PLoS Med. 2015 Oct 06;12(10):e1001885
pubmed: 26440803
J Dev Behav Pediatr. 2006 Oct;27(5):379-85
pubmed: 17041273
Br J Educ Psychol. 2018 Sep;88(3):396-409
pubmed: 28929487
Autism Res. 2016 Jun;9(6):601-15
pubmed: 26451871
J Clin Child Adolesc Psychol. 2008 Jan;37(1):8-38
pubmed: 18444052
New Dir Youth Dev. 2003 Fall;(99):9-15
pubmed: 14635431
BMC Med Inform Decis Mak. 2020 Feb 27;20(1):42
pubmed: 32106861
J Autism Dev Disord. 2020 Feb 28;:
pubmed: 32112234
Aust N Z J Public Health. 2018 Aug;42(4):382-388
pubmed: 29644776
Cerebrum. 2017 Jan 01;2017:
pubmed: 28698772
Pediatrics. 2003 Nov;112(5):1206-9
pubmed: 14595070
Int J Epidemiol. 2019 Jun 1;48(3):677-677e
pubmed: 30793742
J Pers Med. 2021 Jan 25;11(2):
pubmed: 33504019
J Autism Dev Disord. 2020 May;50(5):1683-1700
pubmed: 30805766
J Autism Dev Disord. 2015 Jun;45(6):1513-31
pubmed: 25641004
MMWR Surveill Summ. 2020 Mar 27;69(4):1-12
pubmed: 32214087
J Intellect Disabil Res. 2017 Nov;61(11):1011-1020
pubmed: 28836311
Psychol Bull. 2020 Jan;146(1):1-29
pubmed: 31763860
Autism. 2020 Nov;24(8):2213-2227
pubmed: 32677449

Auteurs

Nicholas Bowden (N)

A Better Start National Science Challenge, Auckland, New Zealand.
Department of Women's and Children's Health, University of Otago, Dunedin, New Zealand.

Sheree Gibb (S)

A Better Start National Science Challenge, Auckland, New Zealand.
Department of Public Health, University of Otago Wellington, Wellington, New Zealand.

Richard Audas (R)

A Better Start National Science Challenge, Auckland, New Zealand.
Department of Women's and Children's Health, University of Otago, Dunedin, New Zealand.

Sally Clendon (S)

Institute of Education, Massey University, Auckland, New Zealand.

Joanne Dacombe (J)

Department of Women's and Children's Health, University of Otago, Dunedin, New Zealand.
Autism New Zealand, Wellington, New Zealand.

Jesse Kokaua (J)

A Better Start National Science Challenge, Auckland, New Zealand.
Va'a O Tautai, Centre for Pacific Health, Division of Health Sciences, University of Otago, Dunedin, New Zealand.

Barry J Milne (BJ)

A Better Start National Science Challenge, Auckland, New Zealand.
Centre of Methods and Policy Application in the Social Sciences, Faculty of Arts, University of Auckland, Auckland, New Zealand.
School of Social Sciences, Faculty of Arts, University of Auckland, Auckland, New Zealand.

Himang Mujoo (H)

Department of Women's and Children's Health, University of Otago, Dunedin, New Zealand.

Samuel William Murray (SW)

CCS Disability Action, Dunedin, New Zealand.

Kirsten Smiler (K)

School of Health, Victoria University of Wellington, Wellington, New Zealand.

Hilary Stace (H)

Health Services Research Centre, Victoria University of Wellington, Wellington, New Zealand.

Larah van der Meer (L)

Autism New Zealand, Wellington, New Zealand.
Faculty of Education, Victoria University of Wellington, Wellington, New Zealand.

Barry James Taylor (BJ)

A Better Start National Science Challenge, Auckland, New Zealand.
Department of Women's and Children's Health, University of Otago, Dunedin, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH